Myths keeping Kentuckians away from telemedicine for opioids

Myths keeping Kentuckians away from telemedicine for opioids

Some Kentuckians don’t start drug treatment not because it’s not available, but because they think they know it. Old ideas about Suboxone, telemedicine, and recovery are keeping us from trying what works.

This article debunks common myths about remote care and support for opioid addiction in Kentucky, along with facts that speak for themselves.

Myth 1: Suboxone just replaces one addiction with another.

The idea that Suboxone just replaces one addiction with another is a myth. Buprenorphine is a partial agonist, has a ceiling effect, and does not produce euphoria at high doses. Doses prescribed for chronic diseases are not addictive. Suboxone is FDA-approved and has been shown to reduce overdose deaths and emergency department visits.

Myth 2: Telemedicine treatment is less legitimate than in-person treatment.

Video visits are still actual treatment. A study of rural opioid programs found that medication retention and compliance were comparable to in-person care. Same provider, same license, same prescribing rules. The only thing that changes is the commute time.

Myth 3: Only a medical professional can prescribe Suboxone.

There is a persistent belief that only specialized health care providers can prescribe Suboxone. This was derived from the old X exemption requirement, which has been removed.

It can now be prescribed by any licensed provider. This change has made treatment more accessible, including through telemedicine in Kentucky.

Myth 4: Medicaid patients cannot initiate treatment remotely.

Although this myth is rooted in real disparities, it does not reflect current policy. Medicaid patients initially started buprenorphine via telemedicine at a lower cost than other patients due to provider participation rather than coverage limitations.

Kentucky Medicaid covers buprenorphine and telehealth, and most plans do not require prior authorization to begin treatment.

Myth 5: Telemedicine does not work in rural and mountainous areas of Kentucky.

While geography seems like an obvious barrier, the real limitation in eastern Kentucky was not telehealth itself, but a lack of health care providers. When patients have access to phones and the internet, they have access to the same health care providers and medications as people in the city.

What is actually restricting access to these areas?

The following factors are more important than distance:

Unreliable broadband or cell phone coverage Older patients may not be comfortable with video Some local pharmacies do not stock buprenorphine

How programs avoid these gaps

There are possible fixes:

If video is not available, an audio-only visit will be allowed Prescriptions will be taken to a pharmacy with supply Care coordinators and family members will provide technology support

The gap is narrowing. Treatments are reaching more people.

Myth 6: Treatment must last forever or there is “no point”

There is a common assumption that MAT only counts if it eventually stops. No other chronic disease conforms to this standard. Buprenorphine does not have a mandatory end date. Some people taper off gradually, while others continue using it for years because it’s effective. Both are recognized as valid outcomes in addiction medicine.

Myth 7: If you use a telemedicine provider, you will lose your local pharmacy or doctor.

People often worry that virtual therapy means starting all over again. That’s not the case. The pharmacy remains the same. Your family doctor will not change. Rather than adding new systems, telehealth providers simply add another layer of support.

What this means for Kentuckians considering treatment

These misconceptions are important because they each cause people to delay receiving the help they already have access to.

Suboxone is medically legal and does not replace one drug with another. Telemedicine follows the same clinical standards as in-person visits. Since the X-waiver ended, more healthcare providers have been able to prescribe Suboxone. Kentucky Medicaid covers telemedicine buprenorphine without the barriers some people expect. The same quality of care is available in rural areas as in cities.

For Kentuckians considering remote opioid treatment or addiction care and support in Kentucky, a licensed health care provider like Aegis Medical USA can clarify coverage and treatment options before committing.

Facebook
Pinterest
LinkedIn
Twitter
Email

Subscribe To Our Newsletter

Subscribe to our email newsletter today to receive updates on the latest news, tutorials and special offers!

Subscribe To Our Newsletter

Subscribe to our email newsletter today to receive updates on the latest news, tutorials and special offers!